Neovasc Inc.
(Toronto Stock Exchange : NVCN)

( )
NVCN After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
-2.11%81.760.6%$363.60m
ISRGIntuitive Surgical, Inc.
1.38%996.217.5%$339.27m
TMOThermo Fisher Scientific Inc.
1.58%176.751.0%$279.38m
BDXBecton, Dickinson and Company
0.60%200.371.3%$246.12m
ABTAbbott Laboratories
1.70%49.710.8%$242.91m
ZBHZimmer Biomet Holdings, Inc.
1.06%113.961.7%$187.14m
ALGNAlign Technology, Inc.
2.72%172.556.2%$183.60m
SYKStryker Corporation
0.25%145.491.3%$157.13m
BCRC. R. Bard, Inc.
0.23%320.151.6%$153.22m
EWEdwards Lifesciences Corporation
-0.04%114.181.2%$151.01m
BAXBaxter International Inc.
1.69%62.141.7%$146.93m
BSXBoston Scientific Corporation
1.17%27.211.1%$144.50m
HOLXHologic, Inc.
-0.08%37.601.6%$143.94m
XRAYDENTSPLY International Inc.
1.71%53.693.0%$108.98m
DXCMDexCom, Inc.
3.90%75.918.7%$105.17m

Company Profile

Neovasc, Inc. operates as a medical device company that develops, manufactures, and markets products for the rapidly growing cardiovascular device marketplace. Its products include the Neovasc Reducer for the treatment of refractory angina and the Tiara technology in development for the transcatheter treatment of mitral valve disease. It operates through the following geographical segments: U.S., Europe, and the Rest of the World. The company was founded on November 2, 2000 and is headquartered in Richmond, Canada.